Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic Acid

Acta Medica Scandinavica

Volumn 223, Issue 5, 1988, Pages 405-418

  Carlson, Lars A ^a   ROSENHAMER, GUNNAR ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

clofibrate; ischaemic heart disease; mortality; nicotinic acid; secondary prevention; serum cholesterol; serum triglycerides

Indexed keywords

CLOFIBRATE; NICERITROL; NICOTINIC ACID;

ADULT; AGE; CONTROLLED STUDY; FATALITY; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION;

AGED; CHOLESTEROL; CLINICAL TRIALS; CLOFIBRATE; COMPARATIVE STUDY; CORONARY DISEASE; FEMALE; HUMAN; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; NICOTINIC ACIDS; PROGNOSIS; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T; SWEDEN; TRIGLYCERIDES;

EID: 0023910325     PISSN: 00016101     EISSN: 09546820     Source Type: Journal    
DOI: 10.1111/j.0954-6820.1988.tb15891.x     Document Type: Article

References (37)

1. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study
2. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project
3. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361662 men
4. Risk factors for ischaemic heart disease in men and women. Results of the 19‐year follow‐up of the Stockholm Prospective Study
5. Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from a 10‐year follow‐up of Uppsala Primary Preventive Study
6. Triglycerides—main lipid risk factor for cardiovascular disease in women
7. A controlled trial of diet high in unsaturated fat in preventing complications of atherosclerosis
8. Effect of cholesterol‐lowering diet on mortality from coronary heart‐disease and other causes
9. Effect of diet and smoking intervention on the incidence of coronary heart disease: report from the Oslo study group of randomized trial in healthy men
10. A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate
11. The Lipid Research Clinics' Coronary Primary Prevention Trial Results
12. The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction
13. Clofibrate and niacin in coronary heart disease
14. Prevention of progression of coronary atherosclerosis by treatment of hyperlipidemia. A 7 year prospective angiographic study
15. Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid
16. Effect of combined clofibrate‐nicotinic acid treatment in ischemic heart disease
17. The effects of serum lipid lowering drugs in secondary prevention of coronary heart disease
18. Use of a single color reagent to improve the automated determination of serum total cholesterol
19. Fluorimetric measurement of triglycerides
20. Serum lipids in normal men
21. Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women
22. Ischaemic heart disease and associated risk factors in 40 year old men in Edinburgh and Stockholm
23. Fibrinogen as a risk factor for stroke and myocardial infarction
24. Hemostatic function and cardiovascular death—early results of a prospective study
25. Fifteen year mortality in coronary drug project patients: long‐term benefit with niacin
26. Serum lipids in men with myocardial infarction
27. Quantitative and qualitative serum lipoprotein analysis. Part 2. Studies in male survivors of myocardial infarction
28. Serum triglycerides—an independent risk factor for myocardial infarction but not for angina pectoris
29. Lipoproteins and atherosclerosis—a look back and a look ahead
30. Hypertriglyceridemia: lipoprotein receptors and atherosclerosis
31. Accumulation of cholesteryl esters and triglycerides in cultured macrophages incubated with plasma very low density lipoproteins from rats fed on casein or soybean protein diets containing moderate levels of cholesterol
32. Lipoprotein metabolism in the macrophage—implications for cholesterol deposition in atherosclerosis
33. Studies in asymptomatic primary hyperlipidaemia. I. Types of hyperlipoproteinaemias and serum lipoprotein concentrations, compositions and interrelations
34. High density lipoproteins as a protective factor against coronary heart disease. The Framingham Study
35. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
36. Plasma plasminogen activator inhibition in myocardial infarction